Jen Greenstein, Ph.D.
About Jen Greenstein, Ph.D.
Jen Greenstein, Ph.D., serves as the Associate Director of Business Development and Investor Engagement at the North Carolina Biotechnology Center, where she has worked since 2020. She holds a Ph.D. in Plant and Microbial Biology from North Carolina State University and has a background in biology and education.
Work at North Carolina Biotechnology Center
Jen Greenstein, Ph.D., serves as the Associate Director of Business Development and Investor Engagement at the North Carolina Biotechnology Center. She has held this position since 2020, contributing to the organization's mission of fostering biotechnology innovation in North Carolina. In her role, she focuses on building relationships with investors and supporting business development initiatives within the biotechnology sector.
Education and Expertise
Jen Greenstein earned her Doctor of Philosophy (Ph.D.) in Plant and Microbial Biology from North Carolina State University, where she studied from 2014 to 2020. She also holds a Master's Degree in Microbial Biotechnology from the same institution, completed between 2012 and 2014. Additionally, she obtained a Bachelor's degree in Biology from the University of North Carolina at Chapel Hill, where she studied from 2006 to 2010. Her educational background provides her with a strong foundation in the life sciences and biotechnology.
Background
Jen Greenstein's academic journey began at the University of North Carolina at Chapel Hill, where she studied Secondary Education and Teaching from 2008 to 2010. This diverse educational background has equipped her with a unique perspective on both the scientific and educational aspects of biotechnology. Her transition from education to advanced studies in biology and biotechnology reflects her commitment to the field.
Contact Information
Jen Greenstein can be reached via email at jen_greenstein@ncbiotech.org. For direct communication, her phone number is 919-549-8846. These contact details facilitate engagement with her regarding business development and investment opportunities in the biotechnology sector.